Pfizer Inc. reports its Q2 earnings soon, carrying the weight of a 10% stock dip this year. The company, known for its ...

Swiss generic drug manufacturer Sandoz plans to launch unbranded weight-loss drugs in Canada at discounts of up to 70% compared to branded versions once patents begin to expire next year, CEO Richard ...

Bristol Myers Squibb offers a 5.6% dividend yield, strong cash flow, and AI-driven growth potential. See why I see this as a ...

Days after he sent letters instructing top pharmaceutical manufacturers to use a "most favored nation" pricing model for ...

President Trump discusses plans to dramatically cut drug prices, matching the lowest rates worldwide and promising ...

Thousands of Medicare recipients will face higher costs for expensive cancer drugs following passage of two provisions in the One Big Beautiful Bill Act, signed by President Donald Trump in July, The ...

"We've cut drug prices by 1,200, 1,300, 1,400, 1,500 percent. I don't mean 50 percent. I mean 14-, 1,500 percent," Trump said ...

Why pharma companies' "price transparency" reports paint a murky picture of how much Americans spend on prescription drugs.

Little-known provisions in the Big Beautiful Bill lobbied by industry will cost Medicare billions in missed savings.